AI Assistant

Carbamazepine (Tegretol)

Organ Function & Health
85.00

Private Carbamazepine (Tegretol) blood test in London for £85, measuring one therapeutic drug marker with results in around 1 business day.

Turnaround time

1 business day

Biomarkers count

1

Reordering your previous test
We've pre-selected your previous add-ons ({{ selectedAddOns.length }}). You can still remove any or add new ones. Pick your clinic and time — the rest is set from your last order.
Enhance Your Panel
{{ availableAddOns.length }} extra tests · sorted by relevance
×
No tests match "{{ addOnSearch }}"
{{ selectedAddOns.length }} test{{ selectedAddOns.length !== 1 ? 's' : '' }} added +£{{ addOnsTotal.toFixed(2) }}
Same-Day Appointments
UKAS Accredited Labs

Book your test

Under 18? Patients under 18 can only be seen at GB Medlabs and Clinilabs, Monday to Friday only.
1
Email
2
Service
3
Details
4
Confirm
{{ emailError }}
Choose Service Type
Home visit

Professional phlebotomist comes to you

+ £{{ home_visit_fee }}

In clinic

Visit our clinic for your test

{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}

Home Visit Details
{{ homeAddressError }}

Home visits require at least 24 hours notice.

{{ homeTimeError }}
Note: Home visits are not available on Sundays
Select a clinic: Sorting by distance…
{{ clinic.name }}

{{ clinicAddress(clinic) }}

{{ clinic.distance.toFixed(1) }} mi
{{ selectedClinic.name }}

{{ clinicAddress(selectedClinic) }}

Select a date
{{ timeSlotAlert }}
Note: Bookings are not available on Sundays
Select an hour

Available time slots: {{ timeSlots.length}}

{{ selectedAddOns.length }} extra test{{ selectedAddOns.length !== 1 ? 's' : '' }} added +£{{ addOnsTotal.toFixed(2) }}
Please confirm your consent before proceeding.

Overview of the Carbamazepine (Tegretol)

The Carbamazepine (Tegretol) blood test is a therapeutic drug-monitoring investigation that measures the concentration of carbamazepine circulating in the blood.

Carbamazepine is a prescription medicine used particularly in the treatment of epilepsy and trigeminal neuralgia and may also be prescribed for selected other neurological or psychiatric conditions.

The relationship between the prescribed dose and the amount of carbamazepine circulating in the blood can vary considerably between individuals. Carbamazepine also stimulates enzymes involved in its own metabolism, meaning concentrations can change after treatment is started or a dose is adjusted.

The test contains 1 biomarker: Carbamazepine (Tegretol). Measurement can provide useful information where treatment response is inadequate, adherence is uncertain, toxicity is suspected or a medicine interaction may have altered drug exposure.

For therapeutic drug monitoring, a trough sample taken immediately before the next scheduled dose is generally preferred because carbamazepine concentrations vary across the dosing interval.

Routine carbamazepine concentration testing is not required for every clinically stable patient. Results are most useful when there is a specific clinical reason for measuring the drug level.

Carbamazepine levels should always be interpreted alongside the prescribed dose, timing of the blood sample, symptoms, other medicines and routine safety monitoring such as Full Blood Count, liver function and electrolytes.

What Does the Carbamazepine (Tegretol) Test Check?

This test measures 1 biomarker.

Therapeutic Drug Monitoring
Carbamazepine (Tegretol)

Measures the concentration of carbamazepine circulating in the blood. The result can support therapeutic drug monitoring where treatment response, adherence, possible toxicity or drug interactions require assessment.

Who May Benefit From the Carbamazepine (Tegretol) Test?

This test may be suitable for people whose clinician is investigating persistent or unusual respiratory symptoms and wants additional information about possible atypical bacterial causes.

Persistent respiratory symptoms - May provide additional laboratory information where coughing, fever or respiratory symptoms have continued longer than expected.

Possible atypical pneumonia - Assesses antibody responses associated with three organisms recognised as causes of atypical respiratory infection.

Prolonged cough - Mycoplasma pneumoniae and Chlamydia pneumoniae can be considered among several possible causes of a persistent cough.

Unexplained fever with respiratory symptoms - Serology may provide supporting information when considered alongside clinical assessment and other investigations.

Possible Mycoplasma pneumoniae exposure - Measures both IgM and IgG antibodies associated with Mycoplasma pneumoniae.

Possible Chlamydia pneumoniae exposure - Measures both IgM and IgG antibodies associated with Chlamydia pneumoniae.

Possible Legionella exposure - Includes Legionella antibody screening within the wider atypical pneumonia assessment.

Respiratory illness that has not followed the expected course - Additional testing may sometimes be considered when symptoms persist despite initial management.

Private specialist respiratory testing - Access the screen through London Blood Tests with clinic and home or hotel phlebotomy options.

How to Prepare

Fasting
Fasting is not normally required for the Carbamazepine (Tegretol) test.
Hydration
Drink water normally before your appointment. Good hydration can make venous blood collection easier.
Medication
Continue carbamazepine exactly as prescribed unless your prescribing clinician specifically instructs otherwise. Do not skip a dose simply to prepare for the test.
Sample timing
A trough sample taken immediately before the next scheduled carbamazepine dose is generally preferred for therapeutic drug monitoring.
Dose details
Record your current carbamazepine dose, dosing schedule and the time your previous dose was taken so the result can be interpreted appropriately.
Other medication
Tell the clinician reviewing your result about all prescription medicines, over-the-counter medicines and supplements because several drugs can alter carbamazepine metabolism.
Recent dose changes
Tell your clinician if your carbamazepine dose has recently changed, as concentrations may not yet reflect the new stable regimen.
Previous results
Keep previous carbamazepine levels, Full Blood Count, liver-function and electrolyte results where available.

Do not increase, reduce, omit or stop carbamazepine simply to influence the laboratory result unless specifically instructed by the clinician responsible for your treatment.

Consistent sample timing is important when comparing repeated carbamazepine measurements because concentrations vary during the dosing interval.

Symptoms and Reasons to Consider the Carbamazepine (Tegretol) Test

You may wish to consider the Carbamazepine (Tegretol) test when treatment is not producing the expected response, toxicity is suspected or a prescribing clinician wants to assess circulating drug concentration.

Unexpected increase in seizures - Loss of seizure control may prompt assessment of adherence, dosing, interactions and carbamazepine concentration.

Dizziness - Dizziness can occur as an adverse effect of carbamazepine, particularly when exposure is excessive.

Unsteadiness or poor coordination - Ataxia can occur with carbamazepine toxicity and may warrant prompt clinical review.

Blurred or double vision - Visual disturbance can occur when carbamazepine concentrations are excessive.

Marked drowsiness - Unusual sedation may occur with higher drug exposure or interactions with other medicines.

Nausea or vomiting - Gastrointestinal symptoms can occur during carbamazepine treatment but are not specific to toxicity.

Confusion - Significant neurological symptoms during treatment require appropriate clinical assessment.

Symptoms following a dose change - New adverse effects after increasing or changing treatment may prompt therapeutic drug monitoring.

Symptoms after starting another medicine - Drug interactions can alter carbamazepine metabolism and may change circulating concentrations.

Carbamazepine concentration is only one part of treatment monitoring. Symptoms can occur even when a measured level falls within the laboratory therapeutic interval, while some people may tolerate concentrations outside a typical reference range.

Severe rash, blistering, fever, mouth ulcers, unusual bruising, significant confusion, severe unsteadiness or rapidly worsening neurological symptoms require prompt medical assessment.

Do not stop carbamazepine suddenly without medical advice, particularly when it is being used to control epilepsy, because abrupt withdrawal can increase seizure risk.

How to Book Your Carbamazepine (Tegretol) Test

Booking your Carbamazepine (Tegretol) test with London Blood Tests is simple and designed to fit around your treatment schedule.

1
Choose the Carbamazepine (Tegretol)

Select the Carbamazepine (Tegretol) test online and review the included therapeutic drug-monitoring biomarker before booking.

2
Select your sample collection option

Choose an in-clinic blood draw (+£35) or a home or hotel phlebotomy visit (+£60) where a qualified phlebotomist collects your sample.

3
Attend your appointment

A trained professional will collect your blood sample, ideally using the timing recommended by your prescribing clinician.

4
Laboratory analysis

Your sample is sent to the laboratory, where the carbamazepine concentration is measured using therapeutic drug-monitoring analysis.

5
Receive your results securely

Your results are sent securely by email, ready to review yourself or discuss with your neurologist, psychiatrist, GP or other prescribing clinician.

When Will I Receive My Results?

The expected turnaround time for the Carbamazepine (Tegretol) test is approximately 1 business day after your sample arrives at the laboratory.

Results are sent securely by email once laboratory analysis and authorisation are complete. Turnaround therefore begins when the laboratory receives the sample rather than necessarily from the time your blood is collected.

Additional laboratory review or repeat analysis may occasionally extend the expected turnaround.

Understanding Your Results

Your Carbamazepine (Tegretol) result shows the concentration of carbamazepine circulating in your blood.

A commonly used therapeutic interval for trough carbamazepine concentrations is approximately 4–12 mg/L, although treatment decisions should not be based on this range alone.

Lower concentrations may occur because of the prescribed dose, missed doses, individual metabolism or interactions with medicines that increase carbamazepine clearance.

Higher concentrations may occur because of excessive dosing, liver dysfunction or interactions with medicines that inhibit carbamazepine metabolism.

Symptoms of excessive exposure can include dizziness, double vision, drowsiness and impaired coordination.

Carbamazepine also induces its own metabolism, so circulating concentrations can change during the first weeks after starting treatment or following dose changes.

The therapeutic interval is a guide rather than an absolute boundary between effective and toxic concentrations. Clinical response, sample timing and individual tolerance remain important.

Do not alter your carbamazepine dose solely because of the laboratory number. The result should be reviewed by the clinician responsible for prescribing and monitoring your medication.

Why Book With London Blood Tests?

Private carbamazepine monitoring in London - Access specialist Carbamazepine (Tegretol) measurement through London Blood Tests.

Targeted therapeutic drug monitoring - Measure carbamazepine independently without having to book a broad health profile.

Useful when seizure control changes - Testing can provide additional information where epilepsy treatment is no longer producing the expected response.

Supports investigation of possible toxicity - Measurement can help assess drug exposure where adverse effects raise concern.

Relevant to medication interaction assessment - Carbamazepine concentrations can change when other medicines alter its metabolism.

Specialist laboratory analysis - Your sample is processed using dedicated therapeutic drug-monitoring methods.

Clinic and home visit options - Choose an in-clinic blood draw or arrange home or hotel phlebotomy depending on location and availability.

Secure results by email - Receive your authorised laboratory result securely once analysis is complete.

Clear pricing before booking - The Carbamazepine (Tegretol) test is priced at £85, with sample collection charges shown separately.

Private Carbamazepine (Tegretol) Blood Test in London

London Blood Tests provides the Carbamazepine (Tegretol) blood test in London for people requiring therapeutic drug monitoring while taking carbamazepine.

The test costs £85 and measures one biomarker: Carbamazepine (Tegretol). Testing can provide useful information about drug exposure where treatment response, adherence, possible toxicity or medication interactions are being investigated.

Clinic appointments are available alongside home and hotel phlebotomy depending on location and availability, providing flexible options for people looking for a private carbamazepine blood test in London or Tegretol level monitoring near them.

Carbamazepine results should be interpreted alongside the dose, timing of the sample, clinical response and routine safety monitoring. Treatment changes should be made by the healthcare professional responsible for prescribing the medicine.

Frequently Asked Questions

It measures the concentration of carbamazepine circulating in your blood.

The test contains 1 biomarker: Carbamazepine (Tegretol).

The test is £85. Sample collection charges apply separately depending on whether you choose an in-clinic or home or hotel appointment.

Drug levels can help assess treatment exposure where response, adherence, possible toxicity or medication interactions require investigation.

A commonly used trough interval is approximately 4–12 mg/L, although individual results must be interpreted clinically.

A trough sample immediately before the next scheduled dose is generally preferred.

No. Continue your medication as prescribed unless your treating clinician gives specific instructions.

No. Routine concentration monitoring is not usually required in every stable patient and is generally performed where there is a specific clinical reason.

Yes. Carbamazepine has numerous drug interactions that can raise or lower circulating concentrations.

Yes. Individual sensitivity varies, so symptoms and clinical findings remain important even when the concentration falls within a typical therapeutic interval.

No. Fasting is not normally required.

Results are expected approximately 1 business day after the sample arrives at the laboratory.
+44 203 488 0809 WhatsApp